Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Heshuo Ephedrine Product Co., Ltd. is a specialized pharmaceutical manufacturer based in the Xinjiang Uygur Autonomous Region of China. The company focuses on the extraction and production of ephedrine and its derivatives from natural Ephedra plants, which are abundant in the local region. Its primary products include Ephedrine Hydrochloride and Pseudoephedrine Hydrochloride, which serve as essential active pharmaceutical ingredients (APIs) for respiratory and allergy medications. As a producer of controlled precursor chemicals, the company operates under stringent regulatory oversight from Chinese health and security authorities. The facility is equipped for large-scale natural product extraction and chemical purification, adhering to national Good Manufacturing Practice (GMP) standards. Its products are supplied to pharmaceutical formulators both within China and in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinjiang Heshuo Ephedrine Product.